Status:
UNKNOWN
Assessment of Score System of Surgery in Necrotizing Enterocolitis(NEC) Patients
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Collaborating Sponsors:
Children's Hospital of Chongqing Medical University
Conditions:
Necrotizing Enterocolitis
Neonate
Eligibility:
All Genders
1-44 years
Brief Summary
Necrotizing enterocolitis(NEC) is one of the most serious disease in the newborn infants, and two and more grades of NEC usually lead to surgery, even death. But, it is difficult to predict when to op...
Detailed Description
Necrotizing enterocolitis(NEC) is characterized by vomit, abdominal distention, hypoactive bowel sounds and bloody stools, even shock, disseminated intravascular coagulation(DIC) and sepsis. X-ray is ...
Eligibility Criteria
Inclusion
- two and more of NEC is diagnosed in the newborn infants
- on the time of diagnosis for NEC both the surgery and non-surgery are reasonable according the surgeon's suggestions
Exclusion
- pneumoperitoneum
- refusing to take part in the study according to parents' decision
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04795453
Start Date
March 1 2021
End Date
December 31 2024
Last Update
October 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chen（陈）
Chongqing, Chongqing Municipality, China, 400014